CAS 2469553-67-9

rac-Ruxolitinib-d9 (major)

Kontrolliertes Produkt

CAS: 2469553-67-9

Applications Labelled racemic analogue of Ruxolitinib (R702000). Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.
References Shilling, A.D. et al.: Drug Metab. Disp., 38, 2023 (2010); Mesa, R.A.: IDrugs, 13, 394 (2010); Campas-Moya, C.: Drugs Fut., 35, 457 (2010);

Formel: C₁₇H₉D₉N₆

Farbe und Form: White To Light Yellow

Molekulargewicht: 315.42

Ref: TR-R701998